Hematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationTransplantation, HomologousTransplantation, AutologousGraft vs Host DiseaseStem Cell TransplantationTransplantation ConditioningBone Marrow TransplantationHematologic NeoplasmsHematopoietic Stem Cell MobilizationStem CellsTreatment OutcomeGranulocyte Colony-Stimulating FactorHematopoietic Stem CellsTissue DonorsTransplantation ChimeraLeukapheresisBusulfanImmunosuppressive AgentsGraft SurvivalMyeloablative AgonistsAntigens, CD34RecurrenceCombined Modality TherapyMelphalanMultiple MyelomaRemission InductionBlood Component RemovalGraft vs Leukemia EffectVidarabineHistocompatibility TestingCord Blood Stem Cell TransplantationCyclophosphamideCytomegalovirus InfectionsAntineoplastic Combined Chemotherapy ProtocolsRetrospective StudiesHistocompatibilityLeukemiaWhole-Body IrradiationGraft vs Tumor EffectSalvage TherapyLeukemia, Myeloid, AcuteDisease-Free SurvivalLeukemia, Myelogenous, Chronic, BCR-ABL PositiveSurvival RateSurvival AnalysisLymphocyte TransfusionLymphocyte DepletionTime FactorsSiblingsLymphoma, Non-HodgkinMyelodysplastic SyndromesPrecursor Cell Lymphoblastic Leukemia-LymphomaNeoplasm, ResidualAnemia, AplasticAntilymphocyte SerumEmbryonic Stem CellsHematologic DiseasesCytomegalovirusEtoposideImmunocompromised HostT-LymphocytesOpportunistic InfectionsInfectionAcute DiseaseVirus ActivationCytarabineBlood CellsHodgkin DiseaseFollow-Up StudiesAdult Stem CellsMesenchymal Stem Cell TransplantationHepatic Veno-Occlusive DiseaseHLA AntigensChimerismMinor Histocompatibility AntigensKidney TransplantationBlood DonorsBlood Cell CountHematopoiesisImmunosuppressionTransplantationFlow CytometryAntineoplastic Agents, AlkylatingFatal OutcomeLeukocyte TransfusionThiotepaCyclosporinePrognosisTransplantation ImmunologyTransplantation, IsogeneicLiver TransplantationAntineoplastic AgentsRoseolovirus InfectionsLeukemia, MyeloidLymphomaGanciclovirBone Marrow CellsBone Marrow PurgingCell Differentiation